Accretion Nutraveda IPO Details
The Accretion Nutraveda IPO is a book build issue with a total issue size of ₹25 cr Accretion Nutraveda IPO opened for subscription on Jan 28, 2026 and closed on Jan 30, 2026. Accretion Nutraveda IPO is set price band at ₹122 to ₹129 per share, with a lot size of 1000 shares. Minimum investment for Retail investors was ₹258,000.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Feb 02, 2026, and listed on both the NSE and BSE on Feb 04, 2026.
Kfin Technologies Limited has been appointed as the registrar. Sobhagya Capital Options Ltd are the Book Running Lead Manager for the issue.
Before investing in the Accretion Nutraveda IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 122 – 129
- Lot Size
- 1000
- Issue Size
- ₹25 Cr
- Minimum Investment
- ₹258000 (2000 Shares)
- Listing Date
- 04 February 2026
Current GMP
₹68 (+52.71%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Accretion Nutraveda Limited
Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products across a wide range of dosage forms, including tablets, capsules, oral liquids, powders, oils, and external applications such as balms, creams, and gels.
The Company operates as a Contract Development and Manufacturing Organization (CDMO), catering to both domestic and international markets. Its international presence spans countries such as Sri Lanka, Singapore, and the United States of America.
Accretion Nutraveda integrates classical Ayurvedic principles with contemporary nutraceutical science to develop products targeting key therapeutic and wellness segments, including:
- Liver care
- Women’s health
- Bone and joint health
- Cognitive health
- Respiratory wellness
Business Verticals
- Domestic Sales and Merchant Exports (Loan License Basis):
This vertical remains the primary revenue contributor, accounting for 96.62% of total revenue in FY 2024–25. - Direct Exports:
Direct exports contributed 38% of revenue, demonstrating consistent growth and reflecting the Company’s expanding international footprint.
Manufacturing Infrastructure
Accretion Nutraveda operates a state-of-the-art manufacturing facility in Gujarat, spread across approximately 10,763 square feet. The facility is equipped with modern infrastructure, including:
- 13 Air Handling Units (AHUs)
- Segregated processing areas for different product categories
- Dedicated quality control and quality assurance systems
The manufacturing unit complies with stringent regulatory and quality standards and holds the following certifications:
- GMP and WHO-GMP
- FSSC 22000
- ISO 9001:2015
- ISO 45001:2018
- Halal Certification
- FSSAI License
Accretion Nutraveda IPO Promoters
- Mr. Mayur Popatlal Sojitra
- Mr. Ankurkumar Shantilal Patel
- Mr. Paraskumar Vinubhai Parmar
- Mr. Hardik Mukundbhai Prajapati
- Mr. Harshad Nanubhai Rathod
- Mr. Vivek Ashok Kumar Patel
Promoters Holding
Holding Pre Issue
100.00%
Holding Post Issue
73.48%
Accretion Nutraveda IPO Objective
The Company Accretion Nutraveda IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Purchase of Machineries for Automation in existing Manufacturing unit
- Purchase of Machineries for New Manufacturing Setup
- Funding working capital requirements of our company
- General corporate purpose
Address / Contact Info
Accretion Nutraveda Ltd.
27 Xcelon Industrial Park-1
Vasna-Chacharwadi, TaSanand,
Ahmedabad, Gujarat, 382213
Phone: +91- 9904366177
Email: compliance@accretionnutraveda.com
Website: http://www.accretionnutraveda.com/
IPO Snapshot
Book Running Lead Managers
- Sobhagya Capital Options Ltd
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Accretion Nutraveda IPO is a Book-building IPO with a total issue size of ₹25 crore. The Accretion Nutraveda IPO price band is ₹122 to 129 per share. The Accretion Nutraveda IPO subscription opens on Wed, Jan 28, 2026, and closes on Fri, Jan 30, 2026. The Accretion Nutraveda IPO will be listed on the BSE. Kfin Technologies Limited is the registrar for the Accretion Nutraveda IPO .
The Accretion Nutraveda IPO opens on Wed, Jan 28, 2026 and closes on Fri, Jan 30, 2026
Accretion Nutraveda IPO Price Band is ₹122 to 129 per share.
Accretion Nutraveda IPO lot size is 1000 shares, Retail investors need a minimum investment of ₹258000 based on the upper price band
The minimum investment for Accretion Nutraveda IPO is ₹258000, based on one lot of 1000 shares at the upper price band of ₹129 per share.
Investors can apply for the Accretion Nutraveda IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Fri, Jan 30, 2026. The application amount remains blocked until the Accretion Nutraveda IPO allotment is finalized.
Accretion Nutraveda IPO issue size is ₹25 crores.
Accretion Nutraveda IPO allotment date is Wed, Jul 1, 2026.
The registrar for Accretion Nutraveda IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited website to check Accretion Nutraveda IPO allotment status, refund processing, and other IPO-related information.
The Accretion Nutraveda IPO GMP (Grey Market Premium) is ₹68 as of Wed, Feb 4, 2026. Based on the upper price band of ₹129 per share, the estimated Accretion Nutraveda IPO listing price is ₹197, indicating a potential listing gain of approximately 0% over the issue price.